|Tested species reactivity||Bovine, Dog, Camelid, Horse, Cat, Ferret, Human, Mink, Non-human primate, Pig, Rabbit|
|Published species reactivity||Not Applicable|
|Host / Isotype||Mouse / IgG2b|
|Immunogen||Human platelet membrane|
|Storage buffer||PBS with 1% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4°C or -20°C if preferred, store in dark|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||Neat|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunocytochemistry (ICC)||See 1 publications below|
Predicted to react with mustelid based on sequence homology.
For FACS analysis, use 10ul of the suggested working dilution to label 1x10^6 cells in 100ul.
CD9 belongs to proteins of tetraspanin family that orchestrate cholesterol-associated tetraspanin-enriched signaling microdomains within the plasma membrane, forming complexes with each other as well as with integrins, membrane-anchored growth factors and other proteins. CD9 is involved in cell motility, osteoclastogenesis, neurite outgrowth, myotube formation and sperm-egg fusion, plays roles in cell attachment and proliferation and is necessary for association of heterologous MHC II molecules on the dendritic cell plasma membrane which is important for effective T cell stimulation. CD9 is also considered as metastasis suppressor in solid tumors.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Not Applicable||Not Cited||
CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.
MA5-16860 was used in immunocytochemistry to determine the contribution of CD151 on breast cancer
|Yang XH,Richardson AL,Torres-Arzayus MI,Zhou P,Sharma C,Kazarov AR,Andzelm MM,Strominger JL,Brown M,Hemler ME||Cancer research (68:3204)||2008|